Chatbot for patient education for prenatal aneuploidy testing: A multicenter randomized controlled trial

Bowdoin Su1, Renee Jones1, Kelly Chen1

  • 1Ariosa Diagnostics, Inc., Roche Diagnostics Solutions, San Jose, CA, USA.

PubMed
Summary

A chatbot significantly improved patient knowledge of prenatal testing options compared to standard care. Both patients and providers reported high satisfaction with the chatbot intervention.